VAISHALI PHARMA
|
VAISHALI PHARMA Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹70 Cr | ₹76 Cr | ₹5,377,389 Cr | ₹60 Cr | ₹75 Cr |
Sales | ₹64 Cr | ₹72 Cr | ₹5,230,769 Cr | ₹58 Cr | ₹72 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹5.58 Cr | ₹4.10 Cr | ₹102,702 Cr | ₹1.11 Cr | ₹2.08 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹0.26 Cr | ₹0.18 Cr | ₹43,918 Cr | ₹0.57 Cr | ₹0.55 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹70 Cr | ₹76 Cr | ₹5,377,389 Cr | ₹60 Cr | ₹75 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-2.42 Cr | ₹-0.04 Cr | ₹29,185 Cr | ₹0.10 Cr | ₹0.89 Cr |
Raw Material Consumed | ₹57 Cr | ₹64 Cr | ₹4,585,962 Cr | ₹51 Cr | ₹68 Cr |
Opening Raw Materials | - | - | - | - | - |
Purchases Raw Materials | - | - | - | - | - |
Closing Raw Materials | - | - | - | - | - |
Other Direct Purchases / Brought in cost | ₹57 Cr | ₹64 Cr | ₹4,585,962 Cr | ₹51 Cr | ₹68 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | - | - | - | - | - |
Electricity & Power | - | - | - | - | - |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1.30 Cr | ₹1.36 Cr | ₹118,766 Cr | ₹1.27 Cr | ₹2.13 Cr |
Salaries, Wages & Bonus | ₹1.18 Cr | ₹1.21 Cr | ₹109,999 Cr | ₹1.18 Cr | ₹2.03 Cr |
Contributions to EPF & Pension Funds | ₹0.04 Cr | ₹0.05 Cr | ₹4,408 Cr | ₹0.05 Cr | ₹0.04 Cr |
Workmen and Staff Welfare Expenses | ₹0.04 Cr | ₹0.06 Cr | ₹665 Cr | ₹0.02 Cr | ₹0.02 Cr |
Other Employees Cost | ₹0.04 Cr | ₹0.04 Cr | ₹3,694 Cr | ₹0.03 Cr | ₹0.04 Cr |
Other Manufacturing Expenses | ₹0.02 Cr | ₹0.02 Cr | ₹1,815 Cr | ₹0.02 Cr | ₹0.03 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹0.02 Cr | ₹0.02 Cr | ₹1,815 Cr | ₹0.02 Cr | ₹0.03 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | - | - | - | - | - |
General and Administration Expenses | ₹1.59 Cr | ₹1.38 Cr | ₹120,227 Cr | ₹1.54 Cr | ₹1.08 Cr |
Rent , Rates & Taxes | ₹0.03 Cr | ₹0.04 Cr | ₹5,682 Cr | ₹0.22 Cr | ₹0.40 Cr |
Insurance | ₹0.01 Cr | ₹0.01 Cr | ₹669 Cr | ₹0.01 Cr | ₹0.03 Cr |
Printing and stationery | ₹0.06 Cr | ₹0.03 Cr | ₹2,295 Cr | ₹0.04 Cr | ₹0.05 Cr |
Professional and legal fees | ₹0.22 Cr | ₹0.29 Cr | ₹31,494 Cr | ₹0.24 Cr | ₹0.15 Cr |
Traveling and conveyance | ₹0.30 Cr | ₹0.12 Cr | ₹3,780 Cr | ₹0.25 Cr | ₹0.26 Cr |
Other Administration | ₹0.98 Cr | ₹0.89 Cr | ₹76,308 Cr | ₹0.79 Cr | ₹0.20 Cr |
Selling and Distribution Expenses | ₹2.69 Cr | ₹2.67 Cr | ₹74,191 Cr | ₹1.07 Cr | ₹1.07 Cr |
Advertisement & Sales Promotion | ₹0.53 Cr | ₹0.09 Cr | ₹6,629 Cr | ₹0.21 Cr | ₹0.20 Cr |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | ₹2.01 Cr | ₹1.46 Cr | ₹51,663 Cr | ₹0.70 Cr | ₹0.81 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹0.15 Cr | ₹1.12 Cr | ₹15,899 Cr | ₹0.17 Cr | ₹0.06 Cr |
Miscellaneous Expenses | ₹0.00 Cr | ₹0.00 Cr | ₹182,439 Cr | ₹4.19 Cr | ₹0.04 Cr |
Bad debts /advances written off | - | - | ₹182,070 Cr | ₹3.47 Cr | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.00 Cr | ₹0.00 Cr | ₹369 Cr | ₹0.72 Cr | ₹0.04 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹60 Cr | ₹69 Cr | ₹5,112,586 Cr | ₹59 Cr | ₹73 Cr |
Operating Profit (Excl OI) | ₹9.38 Cr | ₹6.89 Cr | ₹264,803 Cr | ₹0.90 Cr | ₹2.08 Cr |
Other Income | ₹2.23 Cr | ₹1.79 Cr | ₹180,910 Cr | ₹2.17 Cr | ₹1.98 Cr |
Interest Received | ₹0.08 Cr | ₹0.09 Cr | ₹9,240 Cr | ₹0.09 Cr | ₹0.08 Cr |
Dividend Received | - | - | - | - | ₹0.05 Cr |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹0.10 Cr | ₹0.05 Cr | - | - | - |
Foreign Exchange Gains | ₹0.54 Cr | ₹0.44 Cr | ₹39,848 Cr | ₹0.87 Cr | ₹0.70 Cr |
Others | ₹1.51 Cr | ₹1.21 Cr | ₹131,822 Cr | ₹1.22 Cr | ₹1.16 Cr |
Operating Profit | ₹12 Cr | ₹8.67 Cr | ₹445,713 Cr | ₹3.07 Cr | ₹4.06 Cr |
Interest | ₹2.26 Cr | ₹2.49 Cr | ₹262,568 Cr | ₹2.56 Cr | ₹2.66 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | ₹0.00 Cr |
Other Interest | ₹2.26 Cr | ₹2.49 Cr | ₹262,568 Cr | ₹2.56 Cr | ₹2.66 Cr |
PBDT | ₹9.35 Cr | ₹6.19 Cr | ₹183,146 Cr | ₹0.52 Cr | ₹1.40 Cr |
Depreciation | ₹0.50 Cr | ₹0.46 Cr | ₹42,693 Cr | ₹0.44 Cr | ₹0.27 Cr |
Profit Before Taxation & Exceptional Items | ₹8.85 Cr | ₹5.73 Cr | ₹140,452 Cr | ₹0.08 Cr | ₹1.13 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹8.85 Cr | ₹5.73 Cr | ₹140,452 Cr | ₹0.08 Cr | ₹1.13 Cr |
Provision for Tax | ₹2.24 Cr | ₹1.71 Cr | ₹35,827 Cr | ₹0.05 Cr | ₹0.42 Cr |
Current Income Tax | ₹2.16 Cr | ₹1.46 Cr | ₹37,883 Cr | ₹0.06 Cr | ₹0.40 Cr |
Deferred Tax | ₹0.00 Cr | ₹-0.02 Cr | ₹-2,056 Cr | ₹-0.01 Cr | ₹-0.03 Cr |
Other taxes | ₹0.08 Cr | ₹0.27 Cr | - | - | ₹0.05 Cr |
Profit After Tax | ₹6.60 Cr | ₹4.02 Cr | ₹104,626 Cr | ₹0.03 Cr | ₹0.71 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹7.59 Cr | ₹3.57 Cr | ₹251,892 Cr | ₹2.49 Cr | ₹1.77 Cr |
Appropriations | ₹14 Cr | ₹7.59 Cr | ₹356,518 Cr | ₹2.52 Cr | ₹2.49 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | - | - | - | - |
Equity Dividend % | - | - | - | - | - |
Earnings Per Share | ₹6.26 | ₹3.82 | ₹0.99 | ₹0.03 | ₹1.08 |
Adjusted EPS | ₹0.63 | ₹0.38 | ₹0.10 | - | ₹0.07 |
Compare Income Statement of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹217.3 Cr | -1.8% | 4.5% | 2.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | -1.8% |
4.5% |
2.6% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses